CT
Chemokine Therapeutics Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Salari Hassan, was filed 20 Jan 2009.
Chemokine Therapeutics Corp: what insiders have been doing
Chemokine Therapeutics Corp is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Chemokine Therapeutics Corp has published a filing in the past twelve months. The most recent one dates from 20 January 2009.
Looking back to 2008, when coverage begins, insiders filed 14 purchases and 4 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
19
Thresholds
n/a
Buy Volume
€242,032
14 ops. · all time
Sell Volume
€2,785
4 ops. · all time
Financial data
· cache
Last declaration on 20 January 2009
Declarations19 total
- 256,900 shares@ US$0.01Common StockSEC:0001176256-09-000044:0Canonical exit: 15 Apr 2009 (T+90)
- 314,500 shares@ US$0.015Common StockSEC:0001176256-09-000026:0Canonical exit: 9 Apr 2009 (T+90)
- 34,000 shares@ US$0.01Common StockSEC:0001176256-09-000026:1Canonical exit: 12 Apr 2009 (T+90)
- 100,000 shares@ US$0.085Common StockSEC:0001176256-08-000997:0Canonical exit: 25 Nov 2008 (T+90)
- 1,290,000 shares@ US$0.06Common StockSEC:0001176256-08-000997:1Canonical exit: 25 Nov 2008 (T+90)
- 30,000 shares@ US$0.085Common StockSEC:0001176256-08-000989:0Canonical exit: 20 Nov 2008 (T+90)
- 25,000 shares@ US$0.065Common StockSEC:0001176256-08-000989:1Canonical exit: 20 Nov 2008 (T+90)
- 1,450 shares@ US$0.11Common StockSEC:0001176256-08-000989:2
- 10,000 shares@ US$0.10Common StockSEC:0001176256-08-000989:3
- 9,200 shares@ US$0.10Common StockSEC:0001176256-08-000989:4
- 25,000 shares@ US$0.08Common StockSEC:0001176256-08-000989:5
- 666,666 shares@ US$0.15Common StockSEC:0001176256-08-000790:0Canonical exit: 11 Sept 2008 (T+90)
- 80,000 shares@ US$0.15Common StockSEC:0001176256-08-000791:0Canonical exit: 11 Sept 2008 (T+90)
- 50,000 shares@ US$0.18Common stockSEC:0001179110-08-007881:0Canonical exit: 15 Jul 2008 (T+90)
- 50,000 shares@ US$0.16Common stockSEC:0001179110-08-007655:0Canonical exit: 9 Jul 2008 (T+90)
- 247,100 shares@ US$0.81Common stockSEC:0001176256-08-000142:0
- 312,500 shares@ US$0.20Common StockSEC:0001176256-08-000147:0Canonical exit: 7 May 2008 (T+90)
- 300,000 shares@ US$0.20Common stockSEC:0001176256-08-000145:0Canonical exit: 7 May 2008 (T+90)
- 50,000 shares@ US$0.20Common stockSEC:0001176256-08-000146:0Canonical exit: 7 May 2008 (T+90)
19 of 19 declarations
About Chemokine Therapeutics Corp
Chemokine Therapeutics Corp is a company focused on developing treatments based on chemokines for serious diseases. It is listed on the NASDAQ.